At a glance
ClinicalIndex Comparison RecordN/ACompleted· 119 enrolled
Drug / intervention
WallFlex™ Biliary RX Fully Covered/Uncovered Stent Systemdevice
Likely dose
Not stated in record
Key inclusion· 6
- ✓Age 18 or older
- ✓Suspicion of pancreatic adenocarcinoma with distal biliary obstruction
- ✓Distal biliary obstruction consistent with pancreatic cancer
- ✓Likely indicated for neoadjuvant treatment
Key exclusion· 6
- ✕Benign biliary strictures
- ✕Malignancy secondary to Intraductal Papillary Mucinous Neoplasm
- ✕Surgically altered anatomy precluding ERCP
- ✕Prior biliary drainage with metal stent or multiple plastic stents
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized Controlled Trial Comparing Covered and Uncovered Biliary Self Expanding Metal Stents (SEMS) for Pre-operative Drainage During Neoadjuvant Therapy in Patients With Pancreatic Cancer
In Brief
A clinical study evaluating WallFlex™ Biliary RX Fully Covered/Uncovered Stent System for Pancreatic Cancer. Completed, enrolled 119 participants across 9 sites in 6 countries.
Detailed Summary
The purpose of this study is to demonstrate non-inferiority of Fully Covered biliary SEMS to Uncovered biliary SEMS in biliary drainage for the pre-operative management of biliary obstructive symptoms caused by pancreatic cancer in patients undergoing neoadjuvant therapy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPancreatic Cancer
CountriesBelgium, Canada, Italy, Japan, South Korea, United States
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedSep 2014
Enrollment StartMar 2015
Primary CompletionFeb 2018
Study CompletionApr 2018
TodayJul 2026
First PostedSep 12, 2014
Enrollment StartMar 24, 2015
Primary CompletionFeb 21, 2018
Study CompletionApr 10, 2018
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 11.8 years ago
Interventions
WallFlex™ Biliary RX Fully Covered/Uncovered Stent Systemdevice
Reintervention can occur in Arm 1 or Arm 2 with either a WallFlex™ Biliary RX Fully Covered or Uncovered Stent System